Ben Hardwick

1.0k total citations
17 papers, 581 citations indexed

About

Ben Hardwick is a scholar working on Ophthalmology, Hematology and Rheumatology. According to data from OpenAlex, Ben Hardwick has authored 17 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 9 papers in Hematology and 8 papers in Rheumatology. Recurrent topics in Ben Hardwick's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Systemic Lupus Erythematosus Research (7 papers). Ben Hardwick is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Systemic Lupus Erythematosus Research (7 papers). Ben Hardwick collaborates with scholars based in United Kingdom, France and Mexico. Ben Hardwick's co-authors include Michael W. Beresford, Ashley P Jones, Andrew D. Dick, Athimalaipet V Ramanan, Andrew McKay, Helen Hickey, Patricia Woo, Dyfrig Hughes, Clive Edelsten and Sandrine Compeyrot‐Lacassagne and has published in prestigious journals such as New England Journal of Medicine, NeuroImage and Ophthalmology.

In The Last Decade

Ben Hardwick

15 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Hardwick United Kingdom 10 411 285 240 56 56 17 581
Hanna Säilä Finland 10 45 0.1× 103 0.4× 59 0.2× 48 0.9× 19 0.3× 21 313
H Venning United Kingdom 7 32 0.1× 174 0.6× 74 0.3× 25 0.4× 29 0.5× 10 242
L. Nandini Moorthy United States 14 8 0.0× 272 1.0× 306 1.3× 55 1.0× 14 0.3× 33 550
Marie Skougaard Denmark 10 61 0.1× 80 0.3× 139 0.6× 15 0.3× 6 0.1× 32 315
Pauline Powell United Kingdom 8 92 0.2× 83 0.3× 70 0.3× 13 0.2× 7 0.1× 9 421
Ebony Easley United States 10 26 0.1× 9 0.0× 139 0.6× 15 0.3× 40 0.7× 11 348
Jacob Andersson Sweden 9 14 0.0× 42 0.1× 17 0.1× 15 0.3× 15 0.3× 17 263
Jerome W. Bettman United States 15 271 0.7× 7 0.0× 37 0.2× 49 0.9× 48 0.9× 54 548
Enrique Batlle Spain 10 6 0.0× 120 0.4× 370 1.5× 20 0.4× 26 0.5× 27 461
Samar Tharwat Egypt 8 16 0.0× 32 0.1× 76 0.3× 17 0.3× 7 0.1× 68 269

Countries citing papers authored by Ben Hardwick

Since Specialization
Citations

This map shows the geographic impact of Ben Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Hardwick more than expected).

Fields of papers citing papers by Ben Hardwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Hardwick. The network helps show where Ben Hardwick may publish in the future.

Co-authorship network of co-authors of Ben Hardwick

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Hardwick. A scholar is included among the top collaborators of Ben Hardwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Hardwick. Ben Hardwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Dick, Andrew D., Thomas Jaki, David S. Robertson, et al.. (2025). Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis. Pediatric Rheumatology. 23(1). 55–55. 1 indexed citations
3.
4.
Ormesher, Laura, Stephanie A. Worton, Susanna Dodd, et al.. (2023). CHronic hypERtension and L-citRulline studY (CHERRY): an Early-Phase Randomised Controlled Trial in Pregnancy. Reproductive Sciences. 31(2). 560–568. 2 indexed citations
5.
6.
Froggatt, Katherine, Frances Bunn, Girvan Burnside, et al.. (2020). A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT. Health Technology Assessment. 24(6). 1–140. 34 indexed citations
7.
Ramanan, Athimalaipet V, Andrew D. Dick, Catherine Guly, et al.. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology. 2(3). e135–e141. 76 indexed citations
8.
Ramanan, Athimalaipet V, Andrew D. Dick, Ashley P Jones, et al.. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. Health Technology Assessment. 23(15). 1–140. 20 indexed citations
9.
Horton, Sarah, Ashley P Jones, Catherine Guly, et al.. (2019). Adalimumab in Juvenile Idiopathic Arthritis–Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial. American Journal of Ophthalmology. 207. 170–174. 36 indexed citations
10.
Froggatt, Katherine, Guillermo Pérez Algorta, Frances Bunn, et al.. (2018). Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial. BMJ Open. 8(11). e026531–e026531. 17 indexed citations
11.
Ramanan, Athimalaipet V, Andrew D. Dick, Ashley P Jones, et al.. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC Rheumatology. 2(1). 4–4. 23 indexed citations
12.
Sambrook, Thomas D., Ben Hardwick, Andy J. Wills, & Jeremy Goslin. (2018). Model-free and model-based reward prediction errors in EEG. NeuroImage. 178. 162–171. 23 indexed citations
13.
Hughes, Dyfrig, Catrin Plumpton, Eifiona Wood, et al.. (2018). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology. 126(3). 415–424. 14 indexed citations
14.
Ramanan, Athimalaipet V, Andrew D. Dick, Ashley P Jones, et al.. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine. 376(17). 1637–1646. 238 indexed citations
15.
Jones, Ashley P, Helen Hickey, Paula Williamson, et al.. (2016). Assessing the feasibility of injectable growth-promoting therapy in Crohn’s disease. Pilot and Feasibility Studies. 2(1). 71–71. 2 indexed citations
16.
Ramanan, Athimalaipet V, Andrew D. Dick, Ashley P Jones, et al.. (2016). THU0213 Adalimumab in Combination with Methotrexate for The Treatment of Juvenile Idiopathic Arthritis Associated Uveitis: The Sycamore Trial. Annals of the Rheumatic Diseases. 75. 264–265. 4 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanna Säilä Breakdown of academic impact, for papers by H Venning Breakdown of academic impact, for papers by L. Nandini Moorthy Breakdown of academic impact, for papers by Marie Skougaard Breakdown of academic impact, for papers by Pauline Powell Breakdown of academic impact, for papers by Ebony Easley Breakdown of academic impact, for papers by Jacob Andersson Breakdown of academic impact, for papers by Jerome W. Bettman Breakdown of academic impact, for papers by Enrique Batlle Breakdown of academic impact, for papers by Samar Tharwat
Rankless by CCL
2026